A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease

The atypical antipsychotic ziprasidone has been considered inappropriate for use in patients with Parkinson’s disease (PD), as most atypical antipsychotics worsen parkinsonism. However, the current evidence for safety and efficacy of ziprasidone in PDP has not been evaluated in a systematic fashion....

Descripción completa

Detalles Bibliográficos
Autores principales: Younce, John R., Davis, Albert A., Black, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398550/
https://www.ncbi.nlm.nih.gov/pubmed/30475775
http://dx.doi.org/10.3233/JPD-181448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398550/
https://www.ncbi.nlm.nih.gov/pubmed/30475775
http://dx.doi.org/10.3233/JPD-181448

Ejemplares similares